Table 1.
Baseline clinical and instrumental data of the five patients with psoriasis-related myocarditis.
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
|---|---|---|---|---|---|
| Age/sex | 67/M | 52/M | 54/M | 65/M | 44/M |
| Severity of skin psoriasis | Moderate | Severe | Moderate | Moderate | Severe |
| Presence of arthritis | No | No | Yes | No | Yes |
| Eye involvement | No | No | No | Yes, uveitis |
Yes, uveitis |
| NYHA Class | III | III | III | III | IV |
| ECG | PVC | AF | SVT and NSVT | NSVT | ST-T abn |
| 2D-echocardiogram | |||||
| LVEDD (mm) | 72 | 67 | 55 | 68 | 65 |
| LVEF (%) | 18 | 20 | 30 | 17 | 16 |
| Left atrium (volume, mL) | 60 | 68 | 50 | 70 | 126 |
| E/E’ ratio | 30 | 28 | 22 | 25 | 29 |
| TAPSE (mm) | 14 | 13 | 24 | 18 | 16 |
| Pericardial effusion | No | No | No | Yes | Yes |
| Cardiac magnetic resonance | |||||
| LVEDV (mL/m2) | 108.7 | 131.0 | 130.1 | 114.08 | 217.5 |
| LVESV (mL/m2) | 91.5 | 110.6 | 108.2 | 95.6 | 181.0 |
| LVEF % | 15.8 | 20.3 | 32.7 | 16.1 | 16.7 |
| MWT | 13 | 11 | 10 | 11 | 13 |
| LV mass (g/m2) | 79 | 85.6 | 97.1 | 80.2 | 158.1 |
| Edema | No | No | No | Yes | Yes |
| LGE | Yes | No | No | Yes | Yes |
| T1 global ± SD (ms) | 1285 ± 131 | 1015 ± 153 | 1020 ± 81 | 1056 ± 96 | 1071 ± 52 |
| T2 global ± SD (ms) | 56 ± 14 | 52 ± 9 | 51 ± 6 | 50 ± 8 | 50 ± 6 |
| Coronary arteries | Normal | Normal | Normal | Normal | Normal |
PVC, premature ventricular contractions; AF, atrial fibrillation; SVT, supraventricular tachycardia; NSVT, non-sustained ventricular tachycardia; ST-T abn, ST segment/T-wave abnormalities; LVEDD, left-ventricular and diastolic diameter; LVEF left-ventricular ejection fraction; E/E’ ratio, ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E’); TAPSE, tricuspid annular-plane systolic excursion; LVEDV, left-ventricular end-diastolic volume; LVESV, left-ventricular end-systolic volume; LVM, left-ventricular mass; LGE, late gadolinium enhancement; SD, standard deviation.